Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine

The discovery of monoamine oxidase inhibitors (MAOIs) in the 1950s marked a significant breakthrough in medicine, creating a powerful new category of drug: the antidepressant. In the years and decades that followed, MAOIs have been used in the treatment of several pathologies including Parkinson...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS chemical neuroscience 2023-12, Vol.14 (23), p.4064-4075
Hauptverfasser:	Hoffman, Gavin R, Olson, Madeline G, Schoffstall, Allen M, Estévez, Ryan F, Van den Eynde, Vincent, Gillman, Peter K, Stabio, Maureen E
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressive Agents - therapeutic use Isocarboxazid Monoamine Oxidase Inhibitors - pharmacology Monoamine Oxidase Inhibitors - therapeutic use Phenelzine - pharmacology Phenelzine - therapeutic use Selegiline - pharmacology Selegiline - therapeutic use Tranylcypromine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!